Project Grant R21TW010790

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $614,420 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the Hennepin Healthcare Research Institute (HHRI) to evaluate the effectiveness of the Diabetes Homeless Medication Support (D-HOMES) program. The D-HOMES program provides behavioral support and referrals to community resources to improve medication adherence and glycemic control among adults with type 2...

This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $167,864 to The General Hospital Corporation, doing business as Massachusetts General Hospital, to conduct a mixed-methods study on adapting and developing a diabetes self-management education and support (DSMES) intervention for people with type 2 diabetes experiencing food insecurity. The key objectives of the...

The National Institute on Minority Health and Health Disparities (NIMHD), under the Minority Health and Health Disparities Research program (CFDA 93.307), awarded a $608,701 Project Grant to Arizona State University to implement the "SMARTSTART: A Digitally-Enhanced Diabetes Self-Management Intervention for Low-Income People Newly Diagnosed with Type 2 Diabetes." This grant aims to address the disproportionate burden of poor health outcomes experienced by low-income populations who are...

This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $211,590 to Carnegie Mellon University to conduct research on the time-varying psychosocial influences of blood glucose among adults with type 1 diabetes. The research aims to identify links between mood, stress, social interactions and blood glucose outcomes, as well as investigate self-care behaviors as a...

This Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to address barriers to equitable, guideline-recommended diabetes care in the United States. The research aims to: Describe disparities in diabetes care receipt across individual, neighborhood, and insurance characteristics; Examine disparities in diabetes outcomes and their association with...

This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $583,732 to Emory University to investigate genetic and metabolomic factors associated with Type 2 Diabetes (T2D) and prediabetes phenotypes in the South Asian population. The research aims to: Examine genetic associations with T2D and prediabetes phenotypes, develop polygenic risk...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a 5-year, $271,385 Cooperative Agreement (Award ID: U01DK140735) to the University of Colorado Denver under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The purpose of this award is to investigate the impact of type 1 diabetes (T1D) on neurocognitive and psychosocial functioning in pre-pubertal children. The research will examine the long-term effects of diabetic...

This $644,524 Project Grant award from the National Science Foundation's (NSF) Integrative Activities (CFDA 47.083) program supports a collaborative research project between Howard University and North Carolina A&T State University. The project aims to identify the dynamic structure of the progression to type 2 diabetes (T2D) using mathematical models. Key activities include: Constructing a theoretical threshold to distinguish between diabetes and non-diabetes states, validated using...

This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $200,000.00 in funding to Boston Medical Center Corporation (BMC) to implement and assess the THRIVE-DM intervention. THRIVE-DM aims to maximize the proportion of type 2 diabetes mellitus (T2DM) patients with health-related social needs (HRSN) who successfully connect to and utilize social services to improve their T2DM outcomes....

This Project Grant award of $392,944 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will fund a 5-year research project led by Dr. Katherine Wentzell of Boston College to investigate the impact of financial toxicity on young adults living with type 1 diabetes (T1D). The key objectives of this mixed-methods research project are to: 1) describe the experience of financial toxicity, health...